Colomeu T, de Figueiredo D, de Matos da Silva P, Fernandes L, de Lima Zollner R
Antioxidants (Basel). 2022; 11(8).
PMID: 36009222
PMC: 9405454.
DOI: 10.3390/antiox11081503.
Becerril S, Rodriguez A, Catalan V, Ramirez B, Unamuno X, Portincasa P
Nutrients. 2019; 11(9).
PMID: 31500090
PMC: 6769456.
DOI: 10.3390/nu11092129.
Taylor E, Ryan M
Ther Adv Cardiovasc Dis. 2016; .
PMID: 26985016
PMC: 5065379.
DOI: 10.1177/1753944716637807.
Zahran E, Risha E
Springerplus. 2013; 2(1):94.
PMID: 23667798
PMC: 3647092.
DOI: 10.1186/2193-1801-2-94.
Hannas B, Das P, Li H, LeBlanc G
PLoS One. 2010; 5(8):e12453.
PMID: 20805993
PMC: 2929206.
DOI: 10.1371/journal.pone.0012453.
Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses.
Dai R, Phillips R, Karpuzoglu E, Khan D, Ahmed S
J Immunol. 2009; 183(11):6998-7005.
PMID: 19890039
PMC: 2782783.
DOI: 10.4049/jimmunol.0901737.
Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40.
Niedbala W, Cai B, Liu H, Pitman N, Chang L, Liew F
Proc Natl Acad Sci U S A. 2007; 104(39):15478-83.
PMID: 17875988
PMC: 1978217.
DOI: 10.1073/pnas.0703725104.
Role of nitric oxide in the regulation of T cell functions.
Niedbala W, Cai B, Liew F
Ann Rheum Dis. 2006; 65 Suppl 3:iii37-40.
PMID: 17038470
PMC: 1798386.
DOI: 10.1136/ard.2006.058446.
Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.
Niedbala W, Wei X, Campbell C, Thomson D, Komai-Koma M, Liew F
Proc Natl Acad Sci U S A. 2002; 99(25):16186-91.
PMID: 12451176
PMC: 138586.
DOI: 10.1073/pnas.252464599.
Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.
Jimenez J, Gonzalez-Nicolas J, Alvarez S, Fresno M, Munoz-Fernandez M
J Virol. 2001; 75(10):4655-63.
PMID: 11312336
PMC: 114219.
DOI: 10.1128/JVI.75.10.4655-4663.2001.
Modulation of autoimmune diseases by nitric oxide.
Singh V, Mehrotra S, Narayan P, Pandey C, Agarwal S
Immunol Res. 2000; 22(1):1-19.
PMID: 10945224
DOI: 10.1385/IR:22:1:1.
Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
van De Loo F, Kuiper S, van Enckevort F, Arntz O, van den Berg W
Am J Pathol. 1997; 151(1):177-91.
PMID: 9212744
PMC: 1857913.
Effect of late modulation of nitric oxide production on murine lupus.
Oates J, Ruiz P, Alexander A, Pippen A, Gilkeson G
Clin Immunol Immunopathol. 1997; 83(1):86-92.
PMID: 9073540
PMC: 4570564.
DOI: 10.1006/clin.1997.4332.
A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis.
Scott G, Williams K, Bolton C
Inflamm Res. 1996; 45(10):524-9.
PMID: 8912019
DOI: 10.1007/BF02311090.
The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
Huang F, Feng G, Lindop G, Stott D, Liew F
J Exp Med. 1996; 183(4):1447-59.
PMID: 8666903
PMC: 2192535.
DOI: 10.1084/jem.183.4.1447.
